Oher GLP-1 like lixsenatide (Sanofi Aventis, trade name Lyxumia) and albiglutide (GlaxoSmithKline, trade names Epezan and Tanseum) are currently approved or are under consideration for diabetes treatment (Ladenheim, 2015)
Researchers tracked health records from over 1.7 million people with Type 2 diabetes and found those taking semaglutide were much less likely to develop Alzheimers disease and related dementias
Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A
Intramuscular B is the standard treatment
Third, many GLP-1 users were already borderline deficient before starting therapy, since obesity itself is associated with lower vitamin D levels due to sequestration in adipose tissue
Each 1 mg cartridge can be purchased individually or as part of a complete kit that includes a reusable pen, needle tips, and a carry case for convenient and accurate preparation